Nasdaq

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
BioWorld

Medtronic's Altaviva bags FDA approval for incontinence

Medtronic plc received U.S. FDA approval for Altaviva, a minimally invasive implantable tibial neuromodulation device designed to treat urge urinary incontinence. Insertion near the ankle requires ...
Monthly Prescribing Reference

FDA Clears Implantable Tibial Neuromodulation Device to Treat Urge Urinary Incontinence

After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...
Morningstar

During an Altaviva(TM) Implant, the Patient Talked About Lunch. That Was the Point

The Altaviva™ device was recently named a 2026 Edison Award winner in the Health, Medical and Biotech category. NORTHAMPTON, MA / ACCESS Newswire / April 21, 2026 / When Sarah Tapani sat in on one of ...
MobiHealthNews

FDA approves Medtronic’s multi-implant smart programmer

The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive ...
Nasdaq

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...